During the past decade, Psychiatric Alliance of the Blue Ridge, Inc. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Psychiatric Alliance of the Blue Ridge, Inc." are "Depressive Disorder, Major" (4 trials) and "Obsessive-Compulsive Disorder" (1 trials). Many other conditions were trialed in "Psychiatric Alliance of the Blue Ridge, Inc." in a lesser frequency.

Most popular intervention types in "Psychiatric Alliance of the Blue Ridge, Inc." are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Rapastinel" (4 trials), "Placebo" (2 trials), "BHV-4157" (1 trials) and "Placebo-matching Rapastinel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Psychiatric Alliance of the Blue Ridge, Inc." are 5 trials for "All" genders.

Currently, there are NaN active trials in "Psychiatric Alliance of the Blue Ridge, Inc.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Psychiatric Alliance of the Blue Ridge, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Psychiatric Alliance of the Blue Ridge, Inc., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".